Generation and characterization of inducible KRAB-dCas9 iPSCs from primates for cross-species CRISPRi
Fiona C. Edenhofer,
Anita Térmeg,
Mari Ohnuki,
Jessica Jocher,
Zane Kliesmete,
Eva Briem,
Ines Hellmann,
Wolfgang Enard
Affiliations
Fiona C. Edenhofer
Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität München, 82152 Planegg, Germany
Anita Térmeg
Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität München, 82152 Planegg, Germany
Mari Ohnuki
Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität München, 82152 Planegg, Germany; Institute for the Advanced Study of Human Biology, Kyoto University, Kyoto 606-8501, Japan; Hakubi Center, Kyoto University, Kyoto 606-8501, Japan
Jessica Jocher
Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität München, 82152 Planegg, Germany
Zane Kliesmete
Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität München, 82152 Planegg, Germany
Eva Briem
Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität München, 82152 Planegg, Germany
Ines Hellmann
Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität München, 82152 Planegg, Germany
Wolfgang Enard
Anthropology and Human Genomics, Faculty of Biology, Ludwig-Maximilians-Universität München, 82152 Planegg, Germany; Corresponding author
Summary: Comparisons of molecular phenotypes across primates provide unique information to understand human biology and evolution, and single-cell RNA-seq CRISPR interference (CRISPRi) screens are a powerful approach to analyze them. Here, we generate and validate three human, three gorilla, and two cynomolgus iPS cell lines that carry a dox-inducible KRAB-dCas9 construct at the AAVS1 locus. We show that despite variable expression levels of KRAB-dCas9 among lines, comparable downregulation of target genes and comparable phenotypic effects are observed in a single-cell RNA-seq CRISPRi screen. Hence, we provide valuable resources for performing and further extending CRISPRi in human and non-human primates.